Discontinued formulations Efpeglenatide and taspoglutide Efpeglenatide and taspoglutide were once-promising, long-acting GLP-1 receptor agonists developed for the treatment of T2DM, both designed for once-weekly administration
Our clinical team is available to consult with you on the rationale, proposed formulation, and suitability of this compounded medication for your patients
That evidence does not transfer cleanly to a healthy 44-year-old chasing recovery, sleep, skin or body composition
What lab work is necessary to get a Zepbound prescription
For example, the comparison of Saxenda vs Zepbound provides additional perspective on how different weight loss medications stack up
After its rise in popularity, another medication came onto the scene: tirzepatide